Kymera Therapeutics Inc’s recent filing unveils that its Chief Legal Officer Chiniara Ellen unloaded Company’s shares for reported $68239.0 on Mar 03 ’25. In the deal valued at $30.45 per share,2,241 shares were sold. As a result of this transaction, Chiniara Ellen now holds 80,085 shares worth roughly $2.46 million.
Then, Chadwick Jeremy G sold 1,383 shares, generating $42,113 in total proceeds. Upon selling the shares at $30.45, the Chief Operating Officer now owns 67,800 shares.
Before that, Jacobs Bruce N. sold 7,035 shares. Kymera Therapeutics Inc shares valued at $214,219 were divested by the Chief Financial Officer at a price of $30.45 per share. As a result of the transaction, Jacobs Bruce N. now holds 201,886 shares, worth roughly $6.19 million.
BTIG Research initiated its Kymera Therapeutics Inc [KYMR] rating to a Buy in a research note published on December 10, 2024; the price target was $60. A number of analysts have revised their coverage, including BMO Capital Markets’s analysts, who began to cover the stock in early December with a ‘”a Market perform”‘ rating. Wells Fargo also remained covering KYMR and has increased its forecast on December 02, 2024 with a “an Overweight” recommendation from previously “an Equal weight” rating. Stephens started covering the stock on November 18, 2024. It rated KYMR as “an Overweight”.
Price Performance Review of KYMR
On Tuesday, Kymera Therapeutics Inc [NASDAQ:KYMR] saw its stock jump 1.69% to $30.68. Over the last five days, the stock has lost -11.61%. Kymera Therapeutics Inc shares have fallen nearly -23.74% since the year began. Nevertheless, the stocks have fallen -28.15% over the past one year. While a 52-week high of $53.27 was reached on 01/27/25, a 52-week low of $29.16 was recorded on 03/04/25. SMA at 50 days reached $38.63, while 200 days put it at $41.56.
Levels Of Support And Resistance For KYMR Stock
The 24-hour chart illustrates a support level at 29.51, which if violated will result in even more drops to 28.35. On the upside, there is a resistance level at 31.40. A further resistance level may holdings at 32.13. The Relative Strength Index (RSI) on the 14-day chart is 32.24, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -3.95, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 83.62%. Stochastics %K at 16.41% indicates the stock is a buying.
